Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 35320644

Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2022 Mar 24
First author
Cortés J

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2022 May;19(5):283. doi: 10.1038/s41571-022-00629-x.
    note
    Source null
    related pmid
    35361895
    relationship
    Comment in
  2. citation
    N Engl J Med. 2022 Jun 16;386(24):2346-2347. doi: 10.1056/NEJMc2205309.
    note
    Source null
    related pmid
    35704495
    relationship
    Comment in
  3. citation
    Cell Rep Med. 2022 Jun 21;3(6):100668. doi: 10.1016/j.xcrm.2022.100668.
    note
    Source null
    related pmid
    35732147
    relationship
    Comment in

Authors and identifiers

  1. name
    Cortés J
    type
    Author
  2. name
    Kim SB
    type
    Author
  3. name
    Chung WP
    type
    Author
  4. name
    Im SA
    type
    Author
  5. name
    Park YH
    type
    Author
  6. name
    Hegg R
    type
    Author
  7. name
    Kim MH
    type
    Author
  8. name
    Tseng LM
    type
    Author
  9. name
    Petry V
    type
    Author
  10. name
    Chung CF
    type
    Author
  11. name
    Iwata H
    type
    Author
  12. name
    Hamilton E
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Cortés J
    type
    Author
  2. name
    Kim SB
    type
    Author
  3. name
    Chung WP
    type
    Author
  4. name
    Im SA
    type
    Author
  5. name
    Park YH
    type
    Author
  6. name
    Hegg R
    type
    Author
  7. name
    Kim MH
    type
    Author
  8. name
    Tseng LM
    type
    Author
  9. name
    Petry V
    type
    Author
  10. name
    Chung CF
    type
    Author
  11. name
    Iwata H
    type
    Author
  12. name
    Hamilton E
    type
    Author
bibliography ids
  1. nci-bib-903cb4df639cf00d8f8e4e7c
book metadata
content sha256
99418c5d1a623f25257f44e3722e45d7fefef18b66286942a7751c764c979e6f
document type
citation
dois
  1. 10.1056/NEJMoa2115022
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:35320644
immutable id
pubmed:35320644@99418c5d1a623f25257f44e3722e45d7fefef18b66286942a7751c764c979e6f
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
12
name
The New England journal of medicine
nlm unique id
0255562
pages
1143-1154
volume
386
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2022 May;19(5):283. doi: 10.1038/s41571-022-00629-x.
    note
    Source null
    related pmid
    35361895
    relationship
    Comment in
  2. citation
    N Engl J Med. 2022 Jun 16;386(24):2346-2347. doi: 10.1056/NEJMc2205309.
    note
    Source null
    related pmid
    35704495
    relationship
    Comment in
  3. citation
    Cell Rep Med. 2022 Jun 21;3(6):100668. doi: 10.1016/j.xcrm.2022.100668.
    note
    Source null
    related pmid
    35732147
    relationship
    Comment in
outcomes validated
false
pmid
35320644
provenance
batch id
3f4d1914d2afe41e9e70
provider
NCBI PubMed ESummary
record sha256
ee392e54bc5d19512bf52988f12136898e399cc24d05f3054e13a76318db2301
response sha256
0ceeb248a527e54c6f72dd28d20f7abec08a973fe2e10de00bede4895add09e7
retrieved at
2026-09-09T23:48:06.522634+00:00
publication date
display
2022 Mar 24
precision
day
year
2022
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/35320644/
title
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer.

Preserved source evidence · Not medical advice